xMD Diagnostics, formerly known as Bay Resources Development Group, is a precision diagnostics company headquartered in Annapolis, Maryland. The company's core mission is to enhance the accuracy and efficiency of cancer diagnosis through advanced biotechnology. xMD Diagnostics specializes in high-throughput microdissection technology, offering a range of laboratory instruments and consumables tailored for research, biopharmaceutical, and commercial clinical laboratory markets. Their vision is to significantly improve the diagnostic capabilities of pathologists, oncologists, and other medical professionals.

The company has garnered attention through its innovative approach and has been supported by notable investors in the biotech space. xMD Diagnostics' leadership includes experts in molecular diagnostics and biotechnology, contributing to its strong reputation in the healthcare industry. Key achievements include the development of cutting-edge diagnostic tools that have the potential to transform cancer diagnosis and treatment. Overall, xMD Diagnostics has made a significant impact on precision diagnostics, aiming to improve patient outcomes through technological advancements.